Guggenheim Capital’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,495
| Closed | -$2.06M | – | 1957 |
|
|
2023
Q4 | $2.06M | Sell |
6,495
-573
| -8% | -$181K | 0.02% | 837 |
|
|
2023
Q3 | $1.2M | Buy |
7,068
+345
| +5% | +$58.3K | 0.01% | 1023 |
|
|
2023
Q2 | $1.46M | Sell |
6,723
-188
| -3% | -$40.8K | 0.01% | 986 |
|
|
2023
Q1 | $1.26M | Sell |
6,911
-4,186
| -38% | -$760K | 0.01% | 1059 |
|
|
2022
Q4 | $2.18M | Buy |
11,097
+2,035
| +22% | +$400K | 0.02% | 821 |
|
|
2022
Q3 | $2.04M | Sell |
9,062
-433
| -5% | -$97.4K | 0.02% | 829 |
|
|
2022
Q2 | $1.2M | Sell |
9,495
-575
| -6% | -$72.7K | 0.01% | 1140 |
|
|
2022
Q1 | $1.28M | Buy |
10,070
+549
| +6% | +$69.6K | 0.01% | 1232 |
|
|
2021
Q4 | $1.25M | Buy |
9,521
+412
| +5% | +$54K | 0.01% | 1269 |
|
|
2021
Q3 | $1.11M | Sell |
9,109
-212
| -2% | -$25.9K | 0.01% | 1359 |
|
|
2021
Q2 | $1.06M | Buy |
9,321
+426
| +5% | +$48.6K | 0.01% | 1456 |
|
|
2021
Q1 | $1.07M | Buy |
8,895
+4,242
| +91% | +$510K | 0.01% | 1363 |
|
|
2020
Q4 | $473K | Buy |
+4,653
| New | +$473K | ﹤0.01% | 1659 |
|